The metabolic syndrome components (e.g., abdominal obesity, triglycerides, insulin, HDL-cholesterol, inflammatory markers, etc.)and criteria (e.g., cut-points used to define high-risk values) employed in these studies varied considerably. This evidence concerns the gene INS and Abdominal obesity.